A Study of the Natural Progression of Interstitial Lung Disease (ILD)
| Status: | Recruiting |
|---|---|
| Conditions: | Endocrine, Pulmonary |
| Therapuetic Areas: | Endocrinology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/2/2018 |
| Start Date: | September 2005 |
| End Date: | December 2025 |
| Contact: | Spring Maleckar |
| Phone: | 773-834-4053 |
We propose to acquire data and blood samples on all patients being cared for by the
Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples
from a control group for comparator purposes. In doing so, we will be able to describe the
"phenotypic" expression of these diseases.
Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples
from a control group for comparator purposes. In doing so, we will be able to describe the
"phenotypic" expression of these diseases.
Inclusion Criteria:
- Interstitial lung disease
Exclusion Criteria:
- Does not have Interstitial lung disease
We found this trial at
1
site
5801 South Ellis Avenue
Chicago, Illinois 60637
Chicago, Illinois 60637
773.702.1234
Principal Investigator: Mary E Strek, MD
Phone: 773-702-3609
University of Chicago One of the world's premier academic and research institutions, the University of...
Click here to add this to my saved trials
